Pharmaceuticals news and information

A former senior executive of a pharmaceutical research firm is suing the company, claiming he was fired for taking a stand against its alleged practice of scrutinizing intimate details of job applicants' personal lives.
FULL STORY »

The Food and Drug Administration warned doctors and pharmacists Wednesday to avoid drugs made by a Florida specialty pharmacy called The Compounding Shop, because of potential safety problems uncovered by health inspectors.
FULL STORY »

Total spending on prescription drugs declined last year as more Americans filled prescriptions for lower-cost generics and some filled fewer prescriptions in general, according to a new study.
FULL STORY »

The CVS drugstore chain is getting out of the business of using its data from patient prescription drug records to mail prescription refill notices to customers on behalf of pharmaceutical manufacturers, citing as a reason for the policy change a more stringent provision of the omnibus privacy rule...
FULL STORY »

Roper Industries, Sarasota, Fla., has finished what it started in March, moving deeper into healthcare information technology by completing its announced acquisition of Managed Health Care Associates, Florham Park, N.J., for “approximately $1 billion,” the company has announced.
FULL STORY »

The government is moving the morning-after pill over the counter but only those 15 and older can buy it.
FULL STORY »

The head of Europe's medicines regulator is digging in for a fight over data transparency after being stopped from releasing information on drugs from two U.S. companies by a court ruling.
FULL STORY »

A study of conflicts of interest in leading cancer journals showed financial connections between authors and companies sponsoring phase 3 clinical trials had little impact on interpretation of the results.
FULL STORY »

Canada's largest listed drug maker, Valeant Pharmaceuticals International Inc, is in talks to buy generic drugmaker Actavis Inc for more than $13 billion, a person familiar with the situation told Reuters on Friday night.
FULL STORY »

In an effort to find a treatment for autism, scientists at the University of California, Los Angeles, are leading a $9 million experiment that aims to evaluate the effectiveness of drugs within weeks rather than years.
FULL STORY »